Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT03361605
Eligibility Criteria:
Inclusion Criteria:
1. Must have a body mass index (BMI) less than 30.
2. Must be right handed
3. Must be English speaking
4. Must be capable of giving written informed consent.
5. Must have history of playing tennis (or any type of racquet sport) at least 30 times over lifetime.
Exclusion Criteria:
1. History of obstructive sleep apnea;
2. History of a difficult airway with a previous anesthetic;
3. History of neurological disorders;
4. Hypertension or other cardiovascular abnormalities;
5. Pulmonary hypertension or other pulmonary abnormalities;
6. Gastroesophageal reflux disease (GERD) or heartburn;
7. History of significant head injury with loss of consciousness;
8. Learning disability or other developmental disorder;
9. Allergic reactions to eggs;
10. Pregnant or nursing mothers;
11. Contraindications to neuroimaging methods;
12. Inability or unwilling to fast, or withhold food and liquid intake, for 8 hours prior to your scheduled study visit.
13. Unwilling to abstain from alcohol use for 24 hours prior to your scheduled study visit.
14. History of drug use, or have a positive drug screen.
15. Tattoos on the head or neck region - all other tattoos are subject to determination by investigators.
16. Any impairment, activity or situation that in the judgment of the study coordinator or Principal Investigators would prevent satisfactory completion of the study protocol.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT03361605
Study Brief:
Protocol Section:
NCT03361605